申请人:NIPPON SHINYAKU COMPANY, LIMITED
公开号:EP0359311A2
公开(公告)日:1990-03-21
As a remedy for pollakiuria and other hyperactive bladder as well as other types of urinary incontinences exhibiting anti-cholinergic and calcium antagonistic actions have been found new butynylamine derivatives represented by the following general formula (I) and pharmacological acceptable salts thereof
wherein R¹ and R² are the same or different cycloalkyl, phenyl or 2-thienyl group, R³ and R⁴ are the same or different hydrogen atom or an alkyl group, or together complete a cycloalkyl group in conjunction with the adjacent carbon atoms; R⁵ and R⁶ are the same or different hydrogen atom or an alkyl group, or together complete a cyclic amino group in conjunction with the adjacent nitrogen atom; and A denotes O or NR (in which R is a hydrogen atom or an alkyl group), excluding the case in which R³ and R⁴ are both hydrogen atoms, A is O, and either one of R¹ and R² is phenyl.
作为治疗花粉尿症和其他膀胱过度活跃症以及其他类型尿失禁的药物,发现了由下 列通式(I)代表的新丁炔胺衍生物及其药理学上可接受的盐类,它们具有抗胆碱能和钙拮抗 作用
其中 R¹ 和 R² 是相同或不同的环烷基、苯基或 2-噻吩基,R³ 和 R⁴ 是相同或不同的氢原子或烷基,或与相邻碳原子共同组成环烷基;R⁵ 和 R⁶ 是相同或不同的氢原子或烷基,或与相邻的氮原子共同组成环氨基;A 表示 O 或 NR(其中 R 是氢原子或烷基),不包括 R³ 和 R⁴ 都是氢原子、A 是 O 以及 R¹ 和 R² 中的一个是苯基的情况。